In breast cancer subjects, exercise performed prior to every treatment prevented changes in hemodynamics, including cardiac output, resting heart rate, and systemic vascular resistance, end-diastolic and stroke volumes [29,30] as well as attenuation of the increased NT-proBNP, a diagnostic biomarker for cardiac dysfunction [30]. The gene discussed is NPPB; the disease is breast cancer.